rrd61996_69860.html

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Hc8JNYFIx6U+Q96XB6LNL5NtAIhHwUd26yJTz7Uah+ii0FpVQ2bCtBgeUUGX6WyY 0zVQq1gjc9qQ1IPU2erFxw== 0001181431-05-017379.txt : 20050316 0001181431-05-017379.hdr.sgml : 20050316 20050316204129 ACCESSION NUMBER: 0001181431-05-017379 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050315 FILED AS OF DATE: 20050316 DATE AS OF CHANGE: 20050316 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 BUSINESS PHONE: 805-447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE STREET 2: MAIL STOP 27-3-C CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BALTIMORE DAVID CENTRAL INDEX KEY: 0001185858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 05687192 BUSINESS ADDRESS: STREET 1: AMGEN INC STREET 2: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 4 1 rrd72836.xml FORM 4 X0202 4 2005-03-15 0 0000318154 AMGEN INC AMGN 0001185858 BALTIMORE DAVID ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 0 0 0 Common Stock 5243 D Restricted Stock Units 2005-03-15 4 A 0 1706 0 A 1706 D NQSO (Right to Buy) 58.61 2005-03-15 4 A 0 5000 0 A 2005-03-15 2015-03-15 Common Stock 5000 5000 D (DIR 03.15.05) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. /s/ David Baltimore 2005-03-16 EX-24. 2 rrd61996_69860.htm POWER OF ATTORNEY rrd61996_69860.html

                                                                      EXHIBIT 24
                                                                      ----------

                                POWER OF ATTORNEY

        Know all men by these presents, that the undersigned hereby constitutes
and appoints each of N. Cris Prince, Ana G. Rodriguez, Ellen L. Gams and Mark A.
Schlossberg, signing singly, the undersigned's true and lawful attorney-in-fact
to execute for and on behalf of the undersigned Forms 3, 4 and 5 in accordance
with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the
rules thereunder, as may be required as a result of the undersigned's position
as an officer and/or director of Amgen Inc. (the "Company").

        The undersigned hereby grants to each such attorney-in-fact full power
and authority to execute such Forms 3, 4 and 5 as fully to all intents and
purposes as the undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming all that
such attorney-in-fact, or such attorney-in-fact's substitute or substitutes,
shall lawfully do or cause to be done by virtue of this power of attorney and
the rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934, as amended.

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this ____ day of _______________, 2005.

                                                          ----------------------
                                                          Name:  David Baltimore

-----END PRIVACY-ENHANCED MESSAGE-----